|
Volumn 94, Issue 5, 2000, Pages 563-568
|
Double-blind placebo-controlled trial of Mycobacterium vaccae immunotherapy for tuberculosis in KwaZulu, South Africa, 1991-97
|
Author keywords
Chemotherapy; Clinical trial; Immunotherapy; Mortality; Mycobacterium vaccae; South Africa; Tuberculosis; Weight gain
|
Indexed keywords
BCG VACCINE;
CYTOKINE;
ETHAMBUTOL;
ISONIAZID;
MYCOBACTERIUM VACCINE;
PLACEBO;
PYRAZINAMIDE;
RIFAMPICIN;
STREPTOMYCIN;
TETANUS TOXOID;
ADULT;
ARTICLE;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DOUBLE BLIND PROCEDURE;
ERYTHROCYTE SEDIMENTATION RATE;
FOLLOW UP;
HUMAN;
IMMUNOTHERAPY;
MAJOR CLINICAL STUDY;
MORTALITY;
MYCOBACTERIUM VACCAE;
PHASE 2 CLINICAL TRIAL;
SOUTH AFRICA;
SPUTUM EXAMINATION;
THORAX RADIOGRAPHY;
TREATMENT OUTCOME;
TUBERCULOSIS;
WEIGHT GAIN;
ACTINOBACTERIA (CLASS);
BACTERIA (MICROORGANISMS);
CORYNEBACTERINEAE;
MYCOBACTERIUM BOVIS BCG;
MYCOBACTERIUM VACCAE;
UNCULTURED ACTINOMYCETE;
|
EID: 0033788630
PISSN: 00359203
EISSN: None
Source Type: Journal
DOI: 10.1016/S0035-9203(00)90088-9 Document Type: Article |
Times cited : (23)
|
References (36)
|